Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Time to move to the US

<< Previous

Bullboard Posts

Next >>

Comment by qwerty22on May 18, 2022 3:53pm

58 Views

Post# 34693464

RE:RE:RE:RE:Time to move to the US

Globally science is done in English including the biotech sector. Qs is only doing what everybody else does. Nothing special.

jfm1330 wrote: You don't know what you are talking about. I worked in the biopharma sector in Montreal for a long period and all meetings in the companies I worked for were held in english only because some employees were not speaking french, and these employees never made the efforts to learn it, and most of them were not pure anglophones, they were allophones that realized that in Montreal you can live in english from A to Z without speaking french, and the native french speakers were mostly bilingual and would speak to them in english all the time. So your whole argument is cr*p and people in Quebec, french speaking ones, are the most accommodating people on earth you can find.

jeffm34 wrote:
Yes you are correct. Not many people in North America and the rest of the world can speak French. That is the problem. When the government mandates your company must conduct its business in French you just eliminated 97% of the population to draw your employees from. Companies are no longer allowed to hire the best people for the job. They have to hire the best French speaking people which is a much smaller pool to draw on. That's puts them at a distinct disadvantage.

jfm1330 wrote: Oh! an assimilationist here today. Support Ukraine in their fight against Russia, because they are not Russians, even if a big part of the population speaks russian, and want to share our western values, but Quebec, the only place that is not totally english speaking in North-America should not minimally protect itself against full assimilation and become totally english speaking. By the way, most the inward insular thinker, like me, are able to speak english. How many anglophones in the rest of Canada and the US are able to speak decently in a second language? Yeah! Not many. So, stick your inward insular stuff where I think. And the worst thing, is that there is a chance that you are a Quebecois that wants full assimilation. We have more and more of them these days.

jeffm34 wrote:
If this company wants to be any kind of a major player they need to move now. They will never get the kind of exposure and access to talent needed to take the next step staying where they are now. Once bill 96 passes in Quebec it will further isolate the company from the investment and scientific community. Unfortunately the company will struggle along with their inward insular thinking. Here's a list of places for you Paul. Pick one and go!

https://www.genengnews.com/a-lists/top-10-u-s-biopharma-clusters-6/